TY - JOUR
T1 - Beta-cell function and glucose metabolism in patients with chronic pancreatitis
AU - Ciccarelli, Gea
AU - Di Giuseppe, Gianfranco
AU - Soldovieri, Laura
AU - Quero, Giuseppe
AU - Nista, Enrico Celestino
AU - Brunetti, Michela
AU - Cinti, Francesca
AU - Moffa, Simona
AU - Capece, Umberto
AU - Tondolo, Vincenzo
AU - Mari, Andrea
AU - Gasbarrini, Antonio
AU - Pontecorvi, Alfredo
AU - Alfieri, Sergio
AU - Giaccari, Andrea
AU - Mezza, Teresa
PY - 2024
Y1 - 2024
N2 - Aims: Chronic pancreatitis (CP) is - along with acute pancreatitis - the most frequent cause of diabetes of the exocrine pancreas (DEP). Although insulin deficiency is widely accepted as the major feature of DEP, it is still unclear whether diabetes associated with CP is characterized by additional or different functional defects of the insulin secretory machinery. To identify possible functional defects specifically induced by CP, we performed a cross-sectional study in individuals with normal glucose tolerance (NGT), impaired glucose tolerance (IGT) and diabetes mellitus (DM) comparing patients with and without CP (CP vs. NCP). Methods: We administered an oral glucose tolerance test (OGTT) to all participants and, according to their glucose tolerance, classified them as NGT, IGT and DM. Insulin sensitivity and beta-cell functional parameters were derived from OGTT, hyperglycemic clamp and hyperinsulinemic euglycemic clamp. Results: Studying 146 subjects, we found that beta-cell function and insulin secretion were significantly lower in CP compared to NCP patients. However, when we classified the subjects according to OGTT-derived glucose tolerance, we found no differences in beta-cell function or in insulin sensitivity between CP and NCP with the same glucose tolerance status. Of note, we found that arginine-stimulated insulin secretion is reduced only in subjects with CP and DM compared to NCP subjects with DM. Conclusions: Patients with CP had no specific alterations in insulin secretion and beta-cell function. However, in patients diagnosed with diabetes, we found a lower arginine-stimulated insulin secretion, a marker of reduced functional mass.
AB - Aims: Chronic pancreatitis (CP) is - along with acute pancreatitis - the most frequent cause of diabetes of the exocrine pancreas (DEP). Although insulin deficiency is widely accepted as the major feature of DEP, it is still unclear whether diabetes associated with CP is characterized by additional or different functional defects of the insulin secretory machinery. To identify possible functional defects specifically induced by CP, we performed a cross-sectional study in individuals with normal glucose tolerance (NGT), impaired glucose tolerance (IGT) and diabetes mellitus (DM) comparing patients with and without CP (CP vs. NCP). Methods: We administered an oral glucose tolerance test (OGTT) to all participants and, according to their glucose tolerance, classified them as NGT, IGT and DM. Insulin sensitivity and beta-cell functional parameters were derived from OGTT, hyperglycemic clamp and hyperinsulinemic euglycemic clamp. Results: Studying 146 subjects, we found that beta-cell function and insulin secretion were significantly lower in CP compared to NCP patients. However, when we classified the subjects according to OGTT-derived glucose tolerance, we found no differences in beta-cell function or in insulin sensitivity between CP and NCP with the same glucose tolerance status. Of note, we found that arginine-stimulated insulin secretion is reduced only in subjects with CP and DM compared to NCP subjects with DM. Conclusions: Patients with CP had no specific alterations in insulin secretion and beta-cell function. However, in patients diagnosed with diabetes, we found a lower arginine-stimulated insulin secretion, a marker of reduced functional mass.
KW - Beta-cell function
KW - Insulin secretion
KW - Pancreas
KW - Type 3c diabetes mellitus
KW - Beta-cell function
KW - Insulin secretion
KW - Pancreas
KW - Type 3c diabetes mellitus
UR - http://hdl.handle.net/10807/280685
U2 - 10.1016/j.ejim.2024.06.007
DO - 10.1016/j.ejim.2024.06.007
M3 - Article
SN - 0953-6205
SP - N/A-N/A
JO - European Journal of Internal Medicine
JF - European Journal of Internal Medicine
ER -